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Abstract
Background: Brucellosis, a zoonosis caused by the genus Brucella, has been eradicated in Northern Europe,
Australia, the USA and Canada, but remains endemic in most areas of the world. The strain and biovar typing of
Brucella field samples isolated in outbreaks is useful for tracing back source of infection and may be crucial for
discriminating naturally occurring outbreaks versus bioterrorist events, being Brucella a potential biological warfare
agent. In the last years MLVA-16 has been described for Brucella spp. genotyping. The MLVA band profiles may be
resolved by different techniques i.e. the manual agarose gels, the capillary electrophoresis sequencing systems or
the microfluidic Lab-on-Chip electrophoresis. In this paper we described a high throughput system of MLVA-16
typing for Brucella spp. by using of the microfluidics technology.
Results: The Caliper LabChip 90 equipment was evaluated for MLVA-16 typing of sixty-three Brucella samples.
Furthermore, in order to validate the system, DNA samples previously resolved by sequencing system and Agilent
technology, were de novo genotyped. The comparison of the MLVA typing data obtained by the Caliper
equipment and those previously obtained by the other analysis methods showed a good correlation. However the
outputs were not accurate as the Caliper DNA fragment sizes showed discrepancies compared with real data and a
conversion table from observed to expected data was created.
Conclusion: In this paper we described the MLVA-16 using a rapid, sophisticated microfluidics technology for
detection of amplification product sizes. The comparison of the MLVA typing data produced by Caliper LabChip 90
system with the data obtained by different techniques showed a general concordance of the results. Furthermore
this platform represents a significant improvement in terms of handling, data acquiring, computational efficiency
and rapidity, allowing to perform the strain genotyping in a time equal to one sixth respect to other microfluidics
systems as e.g. the Agilent 2100 bioanalyzer.
Finally, this platform can be considered a valid alternative to standard genotyping techniques, particularly useful
dealing with a large number of samples in short time. These data confirmed that this technology represents a
significative advancement in high-throughput accurate Brucella genotyping.
Background
T h em e m b e r so ft h eg e n u sBrucella are Gram-negative,
facultative intracellular bacteria responsible of a consid-
erable human morbidity and in animals of enormous eco-
nomic losses [1] due to abortion and infertility in
livestock (cattle, goats, and sheep). As brucellosis is a
zoonotic disease, practically all human Brucella infections
develop from direct or indirect contact to animals.
In particular, brucellosis in humans occurs as a sub-acute
or chronic illness, that is generally not lethal in pre-
viously healthy patients, and can result in a wide variety
of manifestations and significant morbidity if the diagno-
sis is unobserved and treatment is not rapidly initiated
[2]. There are nine recognized species of Brucella [3] that
differ in their host preference [4]. In particular, the nine
recognized host-specific Brucella spp. are: B. abortus
which preferentially infects cattle; B. melitensis infects
sheep and goats; B. suis infects pigs; B. canis the dog;
B. ovis, sheep and goats; B. neotomae the desert wood rat;
B. microti the common vole [5]; B.ceti, cetaceans [6];
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species, B. inopinata sp., isolated from a human breast
implant infection, was described [8]. Currently, the divi-
sion in species and between biovars of a given species is
performed using differential tests based on phenotypic
characterization of lipopolysaccharide (LPS) antigens,
phage typing, dye sensitivity, requirement for CO2,H 2S
production, and metabolic properties [9]. The genotyping
of Brucella field strain isolated in outbreaks is an essen-
tial tool to better understand the epidemiology of the dis-
ease and to give support to the trace-back of infection
sources. It is also essential to identify the presence of
Brucella strains that can affect livestock populations and
new strains that were previously considered to be exotic
[10], thus improving the outcomes of the national brucel-
losis eradication programme. Although brucellosis has
been eradicated in Northern Europe, Australia, the USA
and Canada, this disease remains endemic in most areas
of the world [11]. Therefore, the knowledge of the pre-
vailing genotypes of Brucella spp. present in a country is
an important epidemiological tool to assess the necessary
steps required for the formulation of policies and strate-
gies for the control of brucellosis in animal populations.
In addition, Brucella spp. represent potential biological
warfare agents due to the high contagious rates for
humans and animals, the non-specific symptoms asso-
ciated with the infection, and the fact that the organism
can be readily aerosolized [12-14]. Therefore, the discri-
mination between natural outbreaks and/or intentional
release of micro-organism agents may be of crucial
importance in the context of the bioterrorism. Brucella
species are characterised by >80% interspecies homology
by DNA-DNA hybridization studies [15,16] and >98%
sequence similarity by comparative genomics [17]. In
fact, the sequencing of 16 S rRNA showed a 100% of
identity between all of the Brucella spp. [18]. The simple
identification of genus and, in some cases, species by
PCR assays [19,20], is adequate for purposes as diagnosis
of human/animal disease or identification of food con-
tamination but not for the tracing of outbreaks or bioter-
rorist attack. Therefore, the development of strain typing
methods is essential in order to investigate the source of
an epidemic event. Molecular DNA technology such as
repetitive intergenic palindromic sequence-PCR (REP-
PCR) [21], random amplified polymorphic DNA-PCR
(RAPD-PCR) [22], arbitrary primed-PCR (AP-PCR) [23],
amplified fragment length polymorphism (AFLP) [24],
single nucleotide polymorphism (SNP) [25,26], and poly-
merase chain reaction-restriction fragment length poly-
morphism (PCR-RFLP) [27] has been employed to
sub-type Brucella spp.
In the last years the variable number of tandem
repeats (VNTR), allelic hypervariability related to varia-
tion in the number of tandemly repeated sequences,
were used for the discrimination of bacterial species that
display very little genomic diversity. Polymorphic tan-
dem repeat loci have been identified by analysing pub-
lished genome sequences of B. melitensis 16 M, B. suis
1330, and B. abortus 9-941 [16,28]. Schemes based on
multiple locus VNTR analysis (MLVA) were tested. In
Brucella, MLVA schemes with 21 loci (MLVA-21), 15
a n d1 6l o c i( M L V A - 1 5a n dM L V A - 1 6 )w e r ep u b l i s h e d
[12,16,29]. The authors used a subset of loci that pre-
served the clusters corresponding to classical species,
comprising markers with repeat unit sizes of 9 bp or
greater and good species identification capability (’minis-
atellites’)a n dm a r k e r sw i t hr e p e a tu n i ts i z e so fu pt o
8 bp and higher discriminatory power (’microsatellites’)
[30]. The MLVA band profiles may be resolved by dif-
ferent techniques ranging from low cost manual agarose
gels to the more expensive capillary electrophoresis
sequencing systems. The most frequently used method
is the agarose gel. Recently, a more rapid and inexpen-
sive method based on the Lab on a chip technology has
been proposed [31]. This miniaturized platform for elec-
trophoresis applications is able to size and quantify PCR
fragments, and was previously used for studying the
genetic variability of Brucella spp. [32]. Recently a new
high throughput micro-fluidics system, the LabChip 90
equipment (Caliper Life Sciences), was developed. This
platform can be considered particularly useful when
dealing with a large number of samples in short time.
Therefore we evaluated the LabChip 90 system for
MLVA typing of Brucella strains applying the selected
subset of 16 loci proposed by Al-Dahouk et al. [12] to
fifty-three field isolates and ten DNA samples provided
in 2006 for Brucella suis ring-trial. Furthermore, twelve
DNA samples, provided in 2007 for a MLVA VNTR
ring trial and seventeen human Brucella isolates whose
MLVA fingerprinting profiles were previously resolved
[32,33], were de novo genotyped.
Results
By means of MLVA-16 on LabChip 90 (Caliper Life
Sciences) sixty-three DNA samples, fifty-three field iso-
lates of Brucella (Table 1) and ten DNA provided for
Brucella suis ring-trial, were analysed for investigating a
broader number of loci. In order to set up the system,
DNA samples, previously genotyped by sequencing sys-
tem and Agilent technology [32,33], were reanalyzed.
DNA from all ninety-two isolates was amplified at 16
loci (MLVA-16 typing assay) to generate multiple band
profiles. The LabChip 90 equipment acquires the sample
in less than a minute and the analysis of 96 samples in
less than an hour. After PCR amplification 5 μlo fe a c h
reaction was loaded into a 96-well plate and the amplifi-
cation product size estimates were obtained by the
LabChip Gx Software. The data produced by the Caliper
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Page 2 of 9Table 1 The fifty-three strains provided by Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise -
G. Caporale-(Istituto G. Caporale)
Samples Species-biovar according MLVA Database Genotypinga Year Host Geographic origin
BruIT200 B.melitensis biovar 3 2002 human Sardinia, Italy
BruIT201 B.abortus biovar 1 2002 bovine Piemonte, Italy
BruIT202 B.melitensis biovar 3 2002 bovine Lazio, Italy
BruIT203 B.abortus biovar 1 2002 bovine Lazio, Italy
BruIT204 B.abortus biovar 3 2002 bovine Piemonte, Italy
BruIT205 B.melitensis biovar 3 2002 water buffalo Campania, Italy
BruIT206 B.melitensis biovar 3 2002 water buffalo Campania, Italy
BruIT207 B.abortus biovar 1 2003 water buffalo Campania, Italy
BruIT208 B.melitensis biovar 3 2003 milk Emilia-Romagna, Italy
BruIT209 B.melitensis biovar 3 2003 bovine Abruzzo, Italy
BruIT210 B.abortus biovar 3 2001 bovine Piemonte, Italy
BruIT211 B.abortus biovar 3 2001 bovine Piemonte, Italy
BruIT212 B.abortus biovar 3 2002 bovine Piemonte, Italy
BruIT213 B.abortus biovar 3 2007 bovine Italy
BruIT214 B.abortus biovar 3 2002 bovine Piemonte, Italy
BruIT215 B.melitensis biovar 3 2001 ovine Lazio, Italy
BruIT216 B.melitensis biovar 3 2001 ovine Lazio, Italy
BruIT217 B.melitensis biovar 3 2001 water buffalo Lazio, Italy
BruIT218 B.melitensis biovar 3 2002 bovine Campania, Italy
BruIT219 B.melitensis biovar 3 2001 wild boar Campania, Italy
BruIT220 B.melitensis biovar 3 2001 bovine Piemonte, Italy
BruIT221 B.melitensis biovar 3 2001 ovine Piemonte, Italy
BruIT222 B.melitensis biovar 3 2001 ovine Lazio, Italy
BruIT223 B.melitensis biovar 3 2001 ovine Lazio, Italy
BruIT224 B.abortus biovar 3 2001 bovine Lazio, Italy
BruIT225 B.abortus biovar 3 2001 bovine Piemonte, Italy
BruIT226 B.melitensis biovar 3 2001 human Lazio, Italy
BruIT227 B.suis biovar 2 2003 hare Emilia-Romagna, Italy
BruIT228 B.suis biovar 2 2003 hare Emilia-Romagna, Italy
BruIT239 B.abortus biovar 3 2008 bovine Molise, Italy
BruIT240 B.abortus biovar 3 2008 bovine Molise, Italy
BruIT241 B.abortus biovar 3 2008 bovine Molise, Italy
BruIT242 B.abortus biovar 3 2008 bovine Molise, Italy
BruIT243 B.abortus biovar 3 2008 bovine Molise, Italy
BruIT244 B.abortus biovar 3 2008 bovine Molise, Italy
BruIT245 B.abortus biovar 3 2007 water buffalo Campania, Italy
BruIT246 B.melitensis biovar 3 2007 water buffalo Campania, Italy
BruIT247 B.abortus biovar 3 2007 bovine Calabria, Italy
BruIT248 B.abortus biovar 3 2007 water buffalo Puglia, Italy
BruIT249 B.abortus biovar 3 2009 bovine Campania, Italy
BruIT250 B.abortus biovar 3 2009 bovine Calabria, Italy
BruIT251 B.abortus biovar 3 2009 bovine Calabria, Italy
BruIT252 B.abortus biovar 6 2009 bovine Calabria, Italy
BruIT253 B.abortus biovar 6 2009 ovine Puglia, Italy
BruIT254 B.melitensis biovar 3 2001 bovine Piemonte, Italy
BruIT255 B.abortus biovar 3 2002 bovine Piemonte, Italy
BruIT256 B.suis biovar 2 2002 bovine Piemonte, Italy
BruIT257 B.suis biovar 2 2001 ovine Lazio, Italy
BruIT258 B.suis biovar 2 2005 water buffalo Campania, Italy
BruIT259 B.suis biovar 2 2002 wild boar Piemonte, Italy
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Page 3 of 9system showed band sizing discrepancies compared with
data obtained from other electrophoresis platforms.
Therefore a conversion table that would allow the allo-
cation of the correct alleles to the range of fragment
sizes was created. The table contained for each locus
the expected size, the range of observed sizes, including
arithmetical average ± standard deviation, and the corre-
sponding allele (Table 2). The variability range for each
allele was established experimentally by the analysis of
different strain amplification products. Furthermore, in
order to look at intra- and interchip variability, each
allele was analyzed by repeating five times the analysis
on the same chip and different chips. The comparison
of the average and standard deviations obtained by the
analysis of the intra- and interchip variability by t-test
(confidence of interval 95%) shown a P value > 0.005
(data not shown).
The required precision is directly related to the repeat
unit size of the loci. Only data with a standard deviation
lower than the 50% of the repeat unit size were considered
valid. The LabChip 90 equipment MLVA-16 products
were separated and DNA fragment sizes were correlated
to the alleles by the conversion table. Generally, close
alleles were not observed to overlap allowing to assign the
correct allele to each observed value. However, the mar-
kers Bruce 08, Bruce 21, Bruce 16 and Bruce 19 showed
continuity between some neighboring range which may
lead to incorrect assignment of allele to the observed value
(Table 2). The identified species were compared with the
results of the previous analysis [32,33], obtaining a full
concordance for 15 markers while the marker Bruce 19
did not show agreement with the results obtained by the
different analysis systems. For the loci including alleles
spanning into ambiguous ranges, we performed sequen-
cing of the amplicons showing on Caliper maximum or
minimum allele values. Furthermore we performed some
random sequencing of the amplicons obtaining a confir-
mation of the correct assignment (data not shown).
Discussion
Many methods have been developed to differentiate Bru-
cella strains but MLVA currently represents one of the
most promising technologies regarding the epidemiology
of bacteria with a high genetic homogeneity, such as Bru-
cella ssp. In 2003 Bricker et al [28] published a MLVA
based on eight locus scheme. In 2006 Whatmore et al [16]
described a new scheme that included the eight of the ori-
ginal loci of Bricker as well as an additional 13 newly
VNTR loci to give a 21 locus scheme, VNTR-21, that
allowed to provide some resolution at the species level. In
the same year a scheme labelled MLVA-15, based on a
subset of 15 loci that comprises 8 markers with good
species identification capability and 7 with higher discrimi-
natory power, was published [29], and followed by MLVA-
16, a slight modification of MLVA-15 [12]. The different
alleles, amplified by standard PCR techniques, can be ana-
lysed by several electrophoretic techniques as agarose gel,
or capillary electrophoresis sequencing. In this paper the
attention was addressed on the LabChip 90 equipment
(Caliper), a platform based on microfluidics technology
specifically developed for measuring the length of DNA
fragments and that do not require fluorescent primers.
This electrophoresis machine represents a compromise
between the more expensive capillary electrophoresis
apparatus and the traditional agarose gel electrophoresis.
In spite of a lower precision respect to the automated
capillary electrophoresis, the ability to acquire 96 amplifi-
cation product sizes in less than a hour represent an
increased time-reduction over the traditional ethidium
bromide slab gel electrophoresis, with 40-50 amplification
product sizes for the same analysed markers acquired in a
higher time [34]. The LabChip 90 represents also a signifi-
cant improvement respect to other microfluidics systems
as e.g. the Agilent 2100 bioanalyzer (Agilent Technologies,
Palo Alto, Ca). In effect the LabChip 90 allows performing
the strain genotyping in a time equal to one sixth respect
to Agilent. Furthermore this system requires less handling
as a single plate can be read directly after the PCR reac-
tion, while the Agilent equipment needs a manual charge
of the single PCR products for each single chip well.
Finally, the LabChip GX software improves efficiency of
data acquiring by automating the data flows. In fact, the
software allows to export the summary of analysis results
to a spreadsheet application, with the consequent elimina-
tion of the paper-based flows. As described previously
[31,32] the sizing proposed by the Lab on chip technology
does not correspond to the real size, resulting in a shift of
a variable value (offset) respect to the real size estimated
by sequencing. Therefore, a correspondence table which
allows for each range of observed values to assign the
expected size and corresponding allele (Table 2) was cre-
ated. We did not observe in general the overlap among
Table 1 The fifty-three strains provided by Istituto Zooprofilattico Sperimentale dell?’?Abruzzo e del Molise -
G. Caporale-(Istituto G. Caporale) (Continued)
BruIT260 B.abortus biovar 1 2007 bovine Campania, Italy
BruIT261 B.abortus biovar 3 2007 bovine Italy
BruIT262 B.abortus biovar 1 2007 bovine Calabria, Italy
aMLVA bank for bacterial genotyping http://mlva.u-psud.fr/ [35].
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Page 4 of 9Table 2 Comparison between Brucella product sizes estimated by LabChip GX software (Observed size) and actual
sizes obtained by direct sequencing of the PCR product or data available in Genbank (Expected size)
PCR Locus (UL bps)
a Allele Expected size Observed size x ± s
b
Singleplex 1 Bruce08 (18) 2 312
3 330 346-359 352,63 ± 5,37
4 348 369-383 376 ± 4,62
5 366 385-410 399,09 ± 6,58
6 384 411-434 419,29 ± 6,71
Singleplex 2 Bruce43 (12) 1 170 179-188 183,17 ± 2
2 182 191-200 196,07 ± 2,32
3 194
Singleplex 3 Bruce12 (15) 7 302
8 317
9 332
10 347 359-369 362,8 ± 3,7
11 362 379-388 384,13 ± 3,64
12 377 390-400 395,16 ± 3,05
13 ’392 409-420 413 ± 2,55
14 407 424-433 428,82 ± 3,05
15 422 434-440 438,25 ± 2,87
17 452
Singleplex 4 Bruce18 (8) 3 130 143
4 138 150-157 153,57 ± 2,64
5 146 159-162 160,33 ± 1,37
6 154 164-176 171,62 ± 2,95
7 162 178-184 181,65 ± 1,53
8 170 187-194 191 ± 2,24
9 178
Singleplex 5 Bruce11 (63) 2 257 266-270 268 ± 2,82
3 320 321-344 337,82 ± 4,31
4 383 407-422 410,52 ± 3,56
6 509 504-536 515,8 ± 12,52
8 635 623-649 639,6 ± 8,71
9 698 680-724 696,67 ± 15,6
12 887
15 1076
Singleplex 6 Bruce21 (8) 5 140
6 148 162
7 156 178-179 178,5 ± 0,71
8 164 180-186 182,55 ± 1,19
9 172 192-199 194,05 ± 1,94
Singleplex 7 Bruce06 (134) 1 140 151
2 274 282-294 285,9 ± 3,33
3 408 429-454 439,89 ± 6,04
4 542 518-624 575,4 ± 24,92
Singleplex 8 Bruce42 (125) 1 164 172-198 175,1 ± 3,13
2 289 279-298 288,88 ± 2,14
3 414 420-442 428,27 ± 6,18
4 539 504-569 529,31 ± 14,1
5 664 642-647 644 ± 2,64
6 789 695-763 726,4 ± 22,02
7 914
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Page 5 of 9Table 2 Comparison between Brucella product sizes estimated by LabChip GX software (Observed size) and actual
sizes obtained by direct sequencing of the PCR product or data available in Genbank (Expected size) (Continued)
Singleplex 9 Bruce45 (18) 2 133
3 151 156-169 162.01 ± 1,93
4 169
5 187 196-206 198,95 ± 2,63
Singleplex 10 Bruce55 (40) 1 193 204-209 207,05 ± 1,67
2 233 243-259 248,36 ± 4,09
3 273 275-308 282,85 ± 2,5
4 313 327
5 353
6 393 418-422 420,25 ± 1,7
7 433
Singleplex 11 Bruce30 (8) 2 119 130
3 127 132-144 139,29 ± 2,11
4 135 146-152 148,87 ± 1,7
5 143 155-160 157,77 ± 1,78
6 151 165-169 167 ± 2
7 159 174
8 167
9 175
10 183 205-206 202,25 ± 0,5
11 191
12 199
Singleplex 12 Bruce04 (8) 2 152 161-164 162.5 ± 2.1
3 160 169-175 171.6 ± 2
4 168 177-182 179.1 ± 1.3
5 176 185-191 187.3 ± 1.8
6 184 194-198 195.7 ± 1.3
7 192 201-207 203.4 ± 2.2
8 200 213-214 213.7 ± 0.6
9 208 219-222 220.5 ± 2.1
10 216 241
11 224 248-254 250.2 ± 2.4
12 232
13 240
14 248
15 256
17 272
18 280
19 288
20 296
22 312
Singleplex 13 Bruce07 (8) 2 134
3 142
4 150 150-154 151.9 ± 1.5
5 158 157-162 159.8 ± 1.4
6 166 166-171 168.1 ± 1.4
7 174 175-178 176.8 ± 1
8 182 183-186 184.4 ± 1.1
9 190 192-195 195 ± 1.5
10 198 200
11 206
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Page 6 of 9Table 2 Comparison between Brucella product sizes estimated by LabChip GX software (Observed size) and actual
sizes obtained by direct sequencing of the PCR product or data available in Genbank (Expected size) (Continued)
12 214
13 222
14 230
Singleplex 14 Bruce 09 (8) 3 124 131-140 135,52 ± 2,6
4 132 147
5 140 155-158 156,33 ± 1,52
6 148 162-167 165,4 ± 1,89
7 156 172-177 174,42 ± 1,19
8 164 182-187 184,42 ± 1,61
9 172 191-198 193,75 ± 2,5
10 180 201-203 202,12 ± 0,83
11 188 209-212 210,75 ± 1,25
12 196 220
13 204 228-230 228,66 ± 1,15
14 212
15 220
16 228 249-255 252,66 ± 3,21
17 236
18 244 266-271 268,85 ± 1,86
19 252
20 260
22 276
23 284
24 292
Singleplex 15 Bruce 16 (8) 2 144 153-157 154,9 ± 1,59
3 152 158-166 163,04 ± 2,38
4 160 167-172 168,53 ± 1,66
5 168 177-185 181,52 ± 2
6 176 186-194 189,83 ± 2,55
7 184 199-203 200,8 ± 1,4
8 192 207-209 207,66 ± 1,15
9 200 216-219 217,37 ± 1,18
10 208 224-227 224,75 ± 1,5
11 216 231
12 224 242-248 244,75 ± 2,5
14 240
15 248
Singleplex 16 Bruce 19 (6) 4 79
58 5
69 1
15 145
16 151
18 163 173-177 175 ± 1,4
19 169 180-183 182,5 ± 0,5
20 175 184-188 186 ± 1,8
21 181 189-193 190,6 ± 1,2
22 187 194-201 197,9 ± 1,1
23 193 202
25 205
aUnit Length size.
bArithmetic average (x) ± standard deviation (s) of the observed sizes.
De Santis et al. BMC Microbiology 2011, 11:60
http://www.biomedcentral.com/1471-2180/11/60
Page 7 of 9close alleles, allowing to unambiguously assign the correct
allele to each observed value. However, for some contigu-
ous alleles we observed a continuity between ranges which
may lead to incorrect assignment of allele to the observed
value (Table 2). Furthermore, the instrument was not in
agreement with the results obtained by the different analy-
sis systems for the marker Bruce 19. The reduced discri-
minatory ability could be due to the different resolution
achieved by such platform related to the fragment sizes
(routinely ± 10% in a 150-500 -bp range, ± 15% in a
100-150 -bp range and in a 500-1500 -bp range and ± 20%
in a 1500-5000 -bp range). However, the comparison of
the results obtained by the MLVA-16 method on the Cali-
per LabChip 90 platform and those previously resolved by
capillary electrophoresis sequencing system and the Lab
on a chip technology (Agilent Technologies) showed a
good size correlation. Therefore, this platform can be con-
sidered a valid alternative to standard genotyping techni-
que, particularly useful dealing with a large number of
samples in short time.
Conclusion
In this paper we evaluated high throughput system as the
LabChip 90 for MLVA-16 typing of Brucella strains. The
MLVA typing data obtained on this equipment showed
accurate correlation for those obtained by capillary elec-
trophoresis sequencing and the Agilent 2100 Bioanalyzer,
with the exception of Bruce 19. This new platform repre-
sents a significant improvement of the genotyping techni-
ques in terms of turnaround times and computational
efficiency.
Methods
Brucella strains and DNA extraction
In this study fifty-three field isolates submitted for typing
by the Istituti Zooprofilattici Sperimentali to the National
Reference Laboratory for brucellosis at the Istituto Zoo-
profilattico Sperimentale dell’Abruzzo e del Molise-G.
Caporale (Istituto G. Caporale) during the 2001-2008 per-
iod (Table 1), ten DNA samples, collected in UK, provided
at the Istituto Zooprofilattico Sperimentale dell’Abruzzo e
del Molise-G. Caporale (Istituto G. Caporale) for Brucella
suis ring-trial 2006 (COST 845-Brucellosis in man and
animals), seventeen Brucella strains isolated from Sicilian
hospitalized patients with acute brucellosis [33], and
twelve DNA samples, provided by Dr. Falk Melzer for the
Ring trial Brucella 2007 [32], were analysed. The provided
DNA samples were extracted by Maxwell 16 Cell DNA
purification kit (Promega), according to the manufacturer’s
instructions.
VNTR amplification
VNTR amplifications were performed according to the
m e t h o dd e s c r i b e db yL eF l è c h ee ta l .[ 2 9 ]a n dt h e n
adapted by Al Dahouk et al [12]. Sixteen sets of primers
previously proposed were used in sixteen singleplex:
Bruce06, Bruce08, Bruce11, Bruce12, Bruce42, Bruce43,
Bruce45, Bruce55 (panel 1), Bruce18, Bruce 19, Bruce21,
Bruce04, Bruce07, Bruce09, Bruce16, and Bruce30 (panel
2). Amplification reaction mixtures were prepared in 15 μl
volumes using 1U FastStart polymerase Taq (Roche) and
containing 1 ng of DNA, 1 × PCR Roche reaction buffer
( 1 0m MT r i s - H C l ,2 , 5m MM g C l 2 ,5 0m MK C lp H8 . 3 ) ,
0.2 mM dNTPs (Roche) and 0.3 μM of each flanking pri-
mer. The amplification was run in a Peltier Thermal
Cycler DNA Engine DYAD (MJ Research) thermocycler as
follows: an initial heating at 95°C for 5 min, 35 cycles
denaturation at 95°C for 30 sec, annealing at 60°C for
30 sec and extension at 70°C for 60 sec. A final extension
was performed at 70°C for 5 min [32].
MLVA-16 analysis
The amplification was performed in 96-well or 384-well
PCR plates. The chip was prepared according to manufac-
turer recommendations (Caliper HT DNA 5 K Kit). Each
chip contains 5 active wells: 1 for the DNA marker and 4
for gel-dye solution. For each run it was prepared also a
strip well with the ladder (containing eight MW size stan-
dards of 100 300 500 700 1100 1900 2900 4900 bp) that
was inserted into the appropriate groove of the instrument.
The number of samples per chip preparation is 400, equiva-
lent or four 96-well plates or one 384-well plate. After gel
preparation, the sample plate was loaded into the plate
carrier attached to the robot of the Caliper LabChip 90.
During the separation of the fragments, the samples were
analyzed sequentially and electropherograms, virtual gel
images and table data were shown. Amplification product
size estimates were obtained by using the LabChip GX
(Caliper Life Sciences). The software allows importing the
data to a spreadsheet software and subsequently to the con-
version table that, by a special macro set up by our labora-
tory, allows to assign each size to the corresponding allele.
The maximum and minimum value of the observed sizes
for each allele was thus established experimentally while
the arithmetic average and the corresponding standard
deviation (Table 2) were calculated by a statistical function.
Sequencing analysis
The PCR amplicons were purified and sequenced by CEQ
8000 automatic DNA Analysis System (Beckman-Coulter,
Fullerton, CA, USA) using a commercial Kit (Genome-
Lab™ DTCS-Quick Start Kit, Beckman-Coulter) accord-
ing to the manufacturer instructions.
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